Tapewire

Nasdaq · USD

XENE

Xenon Pharmaceuticals Inc.

Export transactions ↓
Tapewire entity
2602
SEC CIK
0001582313
Parsed reports
275

Last 12 months

Inside the activity.

2 purchase rows · 26 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202602
Feb 202600
Mar 2026015
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202603
Sep 202620
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 24, 2023 Filed Aug 24, 2023 20:33 UTC SaleCommon Shares 25,000 $38.70 $967,500.00
Disclosure

SEC source: 0000950170-23-044403 · ownership.xml · nonDerivative · entry 1

Svoronos Dawn · CIK 0001574579 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.70 to $38.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
August 10, 2023 Filed Aug 10, 2023 23:05 UTC GrantStock Option (Right to Buy) · Derivative 28,000 $0.00 Strike: $38.39 $0.00
Disclosure

SEC source: 0000950170-23-041534 · ownership.xml · derivative · entry 1

Gover Justin D. · CIK 0001754129 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,000

Underlying: Common Shares · 28,000 shares

Expires 2033-08-09

F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the first anniversary of August 8, 2023 (the "Start Date"), one-third on the second anniversary of the Start Date and the balance on the third anniversary of the Start Date.

Read SEC document
August 10, 2023 Filed Aug 10, 2023 22:56 UTC GrantStock Option (Right to Buy) · Derivative 28,000 $0.00 Strike: $38.39 $0.00
Disclosure

SEC source: 0000950170-23-041528 · ownership.xml · derivative · entry 1

Cannon Gillian · CIK 0001833910 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,000

Underlying: Common Shares · 28,000 shares

Expires 2033-08-09

F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the first anniversary of August 8, 2023 (the "Start Date"), one-third on the second anniversary of the Start Date and the balance on the third anniversary of the Start Date.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:25 UTC GrantStock Option (Right to Buy) · Derivative 18,475 $0.00 Strike: $38.96 $0.00
Disclosure

SEC source: 0000950170-23-026184 · ownership.xml · derivative · entry 1

GANNON STEVEN · CIK 0001643085 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,475

Underlying: Common Shares · 18,475 shares

Expires 2033-06-01

F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 17:21 UTC GrantStock Option (Right to Buy) · Derivative 18,475 $0.00 Strike: $38.96 $0.00
Disclosure

SEC source: 0000950170-23-026169 · ownership.xml · derivative · entry 1

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,475

Underlying: Common Shares · 18,475 shares

Expires 2033-06-01

F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:27 UTC
PATOU GARYDirector
GrantStock Option (Right to Buy) · Derivative 18,475 $0.00 Strike: $38.96 $0.00
Disclosure

SEC source: 0000950170-23-026190 · ownership.xml · derivative · entry 1

PATOU GARY · CIK 0001283535 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,475

Underlying: Common Shares · 18,475 shares

Expires 2033-06-01

F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 17:29 UTC GrantStock Option (Right to Buy) · Derivative 18,475 $0.00 Strike: $38.96 $0.00
Disclosure

SEC source: 0000950170-23-026195 · ownership.xml · derivative · entry 1

AZAB MOHAMMAD · CIK 0001309653 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,475

Underlying: Common Shares · 18,475 shares

Expires 2033-06-01

F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:20 UTC GrantStock Option (Right to Buy) · Derivative 18,475 $0.00 Strike: $38.96 $0.00
Disclosure

SEC source: 0000950170-23-026167 · ownership.xml · derivative · entry 1

Machado Patrick · CIK 0001311210 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,475

Underlying: Common Shares · 18,475 shares

Expires 2033-06-01

F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:24 UTC GrantStock Option (Right to Buy) · Derivative 18,475 $0.00 Strike: $38.96 $0.00
Disclosure

SEC source: 0000950170-23-026178 · ownership.xml · derivative · entry 1

Svoronos Dawn · CIK 0001574579 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,475

Underlying: Common Shares · 18,475 shares

Expires 2033-06-01

F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting.

Read SEC document
June 02, 2023 Filed Jun 2, 2023 21:22 UTC GrantStock Option (Right to Buy) · Derivative 18,475 $0.00 Strike: $38.96 $0.00
Disclosure

SEC source: 0000950170-23-026171 · ownership.xml · derivative · entry 1

GAROFALO ELIZABETH A. · CIK 0001826361 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,475

Underlying: Common Shares · 18,475 shares

Expires 2033-06-01

F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting.

Read SEC document
June 01, 2023 Filed Jun 1, 2023 19:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $17.76 $0.00
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · derivative · entry 19

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 45,000 shares

Expires 2025-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The shares subject to the options are fully vested and exercisable.

Read SEC document
June 01, 2023 Filed Jun 1, 2023 19:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 9,318 $0.00 Strike: $7.69 $0.00
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · derivative · entry 18

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,682

Underlying: Common Shares · 9,318 shares

Expires 2025-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The shares subject to the options are fully vested and exercisable.

Read SEC document
June 01, 2023 Filed Jun 1, 2023 19:25 UTC SaleCommon Shares 24,255 $38.78 $940,608.90
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 15

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

F9 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.78 to $38.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
June 01, 2023 Filed Jun 1, 2023 19:25 UTC Tax withholdingCommon Shares 20,745 $38.53 $799,304.85
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 14

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,255

F8 · price: Represents the closing price of the Company's common shares on May 31, 2023 for purposes of net settlement calculations.

Read SEC document
June 01, 2023 Filed Jun 1, 2023 19:25 UTC Exercise / conversionCommon Shares 45,000 $17.76 $799,200.00
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 13

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2023 Filed Jun 1, 2023 19:25 UTC SaleCommon Shares 7,458 $38.97 $290,638.26
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 12

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

Read SEC document
June 01, 2023 Filed Jun 1, 2023 19:25 UTC Tax withholdingCommon Shares 1,860 $38.53 $71,665.80
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 11

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,458

F8 · price: Represents the closing price of the Company's common shares on May 31, 2023 for purposes of net settlement calculations.

Read SEC document
June 01, 2023 Filed Jun 1, 2023 19:25 UTC Exercise / conversionCommon Shares 9,318 $7.69 $71,655.42
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 10

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 19:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $17.76 $0.00
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · derivative · entry 17

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Shares · 50,000 shares

Expires 2025-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The shares subject to the options are fully vested and exercisable.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 19:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 29,835 $0.00 Strike: $9.85 $0.00
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · derivative · entry 16

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 29,835 shares

Expires 2024-01-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F10 · derivative.exercise_date: The shares subject to the options are fully vested and exercisable.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 19:25 UTC SaleCommon Shares 26,856 $38.69 $1,039,058.64
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 9

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

F7 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.50 to $38.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 19:25 UTC Tax withholdingCommon Shares 23,144 $38.37 $888,035.28
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 8

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,856

F5 · price: Represents the closing price of the Company's common shares on May 30, 2023 for purposes of net settlement calculations.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 19:25 UTC Exercise / conversionCommon Shares 50,000 $17.76 $888,000.00
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 7

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 19:25 UTC SaleCommon Shares 23,670 $38.81 $918,632.70
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 6

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.66 to $39.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 19:25 UTC Tax withholdingCommon Shares 6,165 $38.37 $236,551.05
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 5

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,670

F5 · price: Represents the closing price of the Company's common shares on May 30, 2023 for purposes of net settlement calculations.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 19:25 UTC Exercise / conversionCommon Shares 29,835 $9.85 $293,874.75
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 4

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,835

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 19:25 UTC SaleCommon Shares 12,000 $38.53 $462,360.00
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 3

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.20 to $38.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
May 30, 2023 Filed Jun 1, 2023 19:25 UTC SaleCommon Shares 19,000 $39.90 $758,100.00
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 2

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
May 30, 2023 Filed Jun 1, 2023 19:25 UTC SaleCommon Shares 18,006 $38.63 $695,571.78
Disclosure

SEC source: 0000950170-23-025802 · ownership.xml · nonDerivative · entry 1

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,000

F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.50 to $39.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 6,172 $0.00 Strike: $9.85 $0.00
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · derivative · entry 13

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 6,172 shares

Expires 2024-01-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The exercise price was converted from $10.78 CAD using the closing rate of exchange of the Bank of Canada on the date of grant, after giving effect to the Reverse Stock Split. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F7 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 20,576 $0.00 Strike: $9.85 $0.00
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · derivative · entry 12

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 20,576 shares

Expires 2024-01-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The exercise price was converted from $10.78 CAD using the closing rate of exchange of the Bank of Canada on the date of grant, after giving effect to the Reverse Stock Split. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F7 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 42,592 $0.00 Strike: $9.44 $0.00
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · derivative · entry 11

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 42,592 shares

Expires 2023-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted from $9.76 CAD using the closing rate of exchange of the Bank of Canada on the date of grant, after giving effect to the 1-for-4.86 reverse stock split of the Issuer's outstanding shares effected October 1, 2014 (the "Reverse Stock Split"). The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F7 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 1,407 $41.49 $58,376.43
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · nonDerivative · entry 9

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,302

F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $41.48 to $41.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Tax withholdingCommon Shares 1,171 $41.84 $48,994.64
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · nonDerivative · entry 8

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,709

F2 · price: Represents the closing price of the Company's common shares on May 23, 2023 for purposes of net settlement calculations.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionCommon Shares 6,172 $9.85 $60,794.20
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · nonDerivative · entry 7

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,880

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The exercise price was converted from $10.78 CAD using the closing rate of exchange of the Bank of Canada on the date of grant, after giving effect to the Reverse Stock Split. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 13,179 $41.37 $545,215.23
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · nonDerivative · entry 6

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,708

F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $41.26 to $41.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Tax withholdingCommon Shares 3,902 $41.84 $163,259.68
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · nonDerivative · entry 5

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,887

F2 · price: Represents the closing price of the Company's common shares on May 23, 2023 for purposes of net settlement calculations.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionCommon Shares 20,576 $9.85 $202,673.60
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · nonDerivative · entry 4

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The exercise price was converted from $10.78 CAD using the closing rate of exchange of the Bank of Canada on the date of grant, after giving effect to the Reverse Stock Split. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 17,069 $41.44 $707,339.36
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · nonDerivative · entry 3

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,213

F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $41.29 to $41.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Tax withholdingCommon Shares 7,310 $41.84 $305,850.40
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · nonDerivative · entry 2

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,282

F2 · price: Represents the closing price of the Company's common shares on May 23, 2023 for purposes of net settlement calculations.

Read SEC document
May 24, 2023 Filed May 26, 2023 23:10 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionCommon Shares 42,592 $9.44 $402,068.48
Disclosure

SEC source: 0000950170-23-024600 · ownership.xml · nonDerivative · entry 1

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted from $9.76 CAD using the closing rate of exchange of the Bank of Canada on the date of grant, after giving effect to the 1-for-4.86 reverse stock split of the Issuer's outstanding shares effected October 1, 2014 (the "Reverse Stock Split"). The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
March 24, 2023 Filed Mar 24, 2023 23:18 UTC
KENNEY CHRISTOPHER JOHNChief Medical Officer
SaleCommon Shares 700 $35.01 $24,507.00
Disclosure

SEC source: 0001209191-23-021136 · doc4.xml · nonDerivative · entry 1

KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:32 UTC
KENNEY CHRISTOPHER JOHNChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 120,000 $0.00 Strike: $34.18 $0.00
Disclosure

SEC source: 0001209191-23-018476 · doc4.xml · derivative · entry 1

KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Shares · 120,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 16:25 UTC
AULIN SHERRYChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 120,000 $0.00 Strike: $34.18 $0.00
Disclosure

SEC source: 0001209191-23-018467 · doc4.xml · derivative · entry 1

AULIN SHERRY · CIK 0001862144 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Shares · 120,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 16:44 UTC
DiFabio AndreaChief Legal Officer
GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $34.18 $0.00
Disclosure

SEC source: 0001209191-23-018501 · doc4.xml · derivative · entry 1

DiFabio Andrea · CIK 0001692506 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Shares · 45,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:47 UTC
Von Seggern ChristopherChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 90,000 $0.00 Strike: $34.18 $0.00
Disclosure

SEC source: 0001209191-23-018508 · doc4.xml · derivative · entry 1

Von Seggern Christopher · CIK 0001821192 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Shares · 90,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:46 UTC
ROBIN SHERRINGTONEVP, Strategy & Innovation
GrantStock Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $34.18 $0.00
Disclosure

SEC source: 0001209191-23-018505 · doc4.xml · derivative · entry 1

ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Shares · 75,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:36 UTC
MORTIMER IANDirector · PRESIDENT & CEO
GrantStock Option (Right to Buy) · Derivative 380,000 $0.00 Strike: $34.18 $0.00
Disclosure

SEC source: 0001209191-23-018482 · doc4.xml · derivative · entry 1

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380,000

Underlying: Common Shares · 380,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:27 UTC
EMPFIELD JAMES R.EVP, Drug Discovery
GrantStock Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $34.18 $0.00
Disclosure

SEC source: 0001209191-23-018470 · doc4.xml · derivative · entry 1

EMPFIELD JAMES R. · CIK 0001665430 · EVP, Drug Discovery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Shares · 75,000 shares

Expires 2033-03-09

F1 · derivative.exercise_date: Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 18:21 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 30,864 $0.00 Strike: $2.59 $0.00
Disclosure

SEC source: 0001209191-23-017636 · doc4.xml · derivative · entry 8

PIMSTONE SIMON N. · CIK 0001620084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 30,864 shares

Expires 2023-03-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

F5 · derivative.exercise_date: The shares subject to the options are fully vested and exercisable.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.